FDA clears the Philips SmartSpeed MR acceleration software.
Citrus Pharmaceuticals says it will submit a BLA to FDA later this year for its I/ONTAK T-cell lymphoma treatment.
FDA lifts its clinical hold on a Greenwich LifeSciences Phase 3 trial of the companys invasive breast cancer investigational treatment.
Catalyst says it has settled its patent litigation with Jacobus over Catalysts Firdapse and Jacobus Ruzurgi.
Federal Register notice: FDA extends the comment period on a draft guidance entitled Risk Management Plans to Mitigate the Potential for Drug Shortage...
FDA warns Elite Supplement Center that it is illegally marketing selective androgen receptor modulator products that are legally considered to be unap...
FDA accepts for review a Byondis BLA for SYD985 ([vic-] trastuzumab duocarmazine) for use in patients with HER2-positive unresectable locally advanced...
FDA grants an emergency use authorization to Watmind USA for its over-the-counter at-home Covid-19 antigen test.